Registered Kenya · PPB

MONOPAS GRANULES

PAS SODIUM GRANULES 60% W/W (DELAYED RELEASE)

H2008/18822/ 295 AMINOSALICYLATE SODIUM USP 600 MG

What it does

Pas is a medication used to treat various conditions. Specific details about its uses and interactions are not provided.

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2008/18822/ 295
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
PAS SODIUM GRANULES 60% W/W (DELAYED RELEASE)
Dosage form
AMINOSALICYLATE SODIUM USP 600 MG
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Sai Pharmaceuticals
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
Whitefield Edge, Junction of James Gichuru Road and Olengurone Road Lavington Nairobi KE, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 21:57:33 · updated 2026-03-23 04:42:41

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Pas is a medication used to treat various conditions. Specific details about its uses and interactions are not provided.

How it works

The exact way Pas works is not specified, but it helps manage certain health conditions.

Who it's for

Pas may be prescribed to individuals with specific health issues, but details are not given.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.